# Safety and PK/PD of RTA 1701 in Healthy Adults

> **NCT03579030** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 90 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo oral capsule
- **DRUG:** RTA 1701 capsules

## Key facts

- **NCT ID:** NCT03579030
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579030, "Safety and PK/PD of RTA 1701 in Healthy Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03579030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*